Skip to Content
Stock Analyst Update

IBM Sees Improvement in Second Quarter

We are maintaining our $168 fair value estimate and narrow economic moat rating for the firm.

Mentioned:

 IBM's (IBM) second-quarter result marked an improvement in the company's underlying growth rate with management touting that its constant currency growth rate of 2% year over year was the best in seven years. However, in what's become commonplace, the firm's balancing act between higher growth strategic and low-to-declining nonstrategic imperatives continues to overhang the company, which is expected to keep the firm's top line suppressed over the midterm. The performance of the systems business (which is benefiting from the recent release of the z14 mainframe product line) certainly bolstered IBM's quarterly result, but we expect the cyclicality of this business to provide only a periodic boost given traditional mainframe refresh cycles. Over the midterm, one green shoot we are more focused on is IBM's services businesses, which encapsulates both global business services, or GBS, and technology services & cloud platforms, or TS&CP. In what has been a long-term struggle, both businesses posted year-over-year growth (albeit very modest). Still, we think IBM's world class services organization continues to have an important role in providing digital transformation services, particularly around hybrid cloud management and managed security services. If IBM can successfully reinvigorate these services businesses and generate more industry-like growth, we would become more bullish on the name (we'll monitor services signings and cloud-related growth in the interim). Nevertheless, with management reiterating it full-year outlook and our view unchanged, we are maintaining our $168 fair value estimate and narrow economic moat rating. With shares approaching 3-star territory in after-hours trade, we think the firm is only modestly undervalued, although it may appeal to dividend seeking technology investors.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Andrew Lange does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.